The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Thu, June 30, 2022 | 00:47
Health & Science
COVID-19 antiviral pills to arrive in Korea next week: PM
Posted : 2022-01-07 09:44
Updated : 2022-01-07 17:12
Print Preview
Font Size Up
Font Size Down


                                                                                                 Prime Minister Kim Boo-kyum speaks at a COVID-19 response meeting in Seoul, Jan. 7. Yonhap
Prime Minister Kim Boo-kyum speaks at a COVID-19 response meeting in Seoul, Jan. 7. Yonhap

Antiviral COVID-19 pills will arrive in South Korea next week, Prime Minister Kim Boo-kyum said Friday.

"We will make sure they can be used swiftly," Kim said during a COVID-19 response meeting in Seoul.

Daily virus cases fall below 4,000 for first time in 3 days amid Omicron fears
Daily virus cases fall below 4,000 for first time in 3 days amid Omicron fears
2022-01-07 12:23  |  Health & Science

The government has so far secured oral COVID-19 drugs for around 1 million patients.

The country signed a pre-purchase contract with U.S. drug giant Pfizer for its Paxlovid pill for 762,000 patients. It also inked a deal with MSD, a subsidiary of U.S. drugmaker Merck, for the pre-purchase of oral coronavirus medications for 242,000.

The first shipment of COVID-19 pills is expected to arrive around Thursday. The government will announce its plan on the imported oral virus treatments in detail next week.

To cope with the fast spread of the Omicron variant of COVID-19, Kim called for an overhaul of the medical response system in terms of pace and efficiency.

He said the health authorities will set priorities for people subject to virus diagnostic tests, so that those who have higher risk of infections can be checked quickly with polymerase chain reaction tests.

Kim also requested a court to make a quick decision on the vaccine pass system, which requires proof of vaccination or negative test results when visitors enter certain facilities.

On Tuesday, the country suspended the vaccine pass mandate for cram schools and other private education facilities following a court ruling that the system infringes on people's right to learn.

The government has said it will appeal the decision, saying the vaccine pass is crucial to protecting unvaccinated patients and for the country's medical response system.

"I understand it is a process of social discussion to find balance between virus prevention and human rights," Kim said. "If it needs improvement, the government will do it with an open mind. But if this confusion and conflict are prolonged, it is the people who will be hurt." (Yonhap)

 
LG
LG
  • Bodies found in missing family's car in Wando
  • Korea looks to Europe to diversify trade partners as China's growth slows
  • [INTERVIEW] 'Asia-Pacific region has potential to lead global decarbonization sector'
  • How I lost my period after shooting my first 'body profile'
  • Yoon, first lady attend gala dinner hosted by King of Spain
  • Inflation expectations in S. Korea hit 10-year high in June
  • Luna collapse causes chaos
  • South Korea's new COVID-19 cases back up over 10,000 after 20 days
  • Korea's first NATO summit to show expanded global role: experts
  • ASEAN F&B industry eyes sustainable market in Korea
  • [INTERVIEW] With unusual nicknames and backgrounds, MIRAE eyes becoming next big K-pop star [INTERVIEW] With unusual nicknames and backgrounds, MIRAE eyes becoming next big K-pop star
  • [INTERVIEW] Jean-Michel Othoniel's glass garden of enchantment 'is for everybody' [INTERVIEW] Jean-Michel Othoniel's glass garden of enchantment 'is for everybody'
  • Girl group aespa to perform in 'Good Morning America' 2022 Summer Concert Series Girl group aespa to perform in 'Good Morning America' 2022 Summer Concert Series
  • Park Hae-il 'honored' to play war hero Admiral Yi Sun-sin in 'Hansan' Park Hae-il 'honored' to play war hero Admiral Yi Sun-sin in 'Hansan'
  • BTS' J-Hope to prerelease 'More' Friday BTS' J-Hope to prerelease 'More' Friday
DARKROOM
  • Afghanistan earthquake killed more than 1,000 [PHOTOS]

    Afghanistan earthquake killed more than 1,000 [PHOTOS]

  • Divided America reacts to overturn of Roe vs. Wade

    Divided America reacts to overturn of Roe vs. Wade

  • Namaste: Yogis to celebrate International Yoga Day

    Namaste: Yogis to celebrate International Yoga Day

  • Poor hit harder by economic crisis

    Poor hit harder by economic crisis

  • Roland Garros 2022

    Roland Garros 2022

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group